Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,465Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Astellas Pharma AG

02 9Astellas Pharma Europe BV

03 2Astellas Pharma Europe BV,

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 50 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 25 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depottablett

Dosage Strength : 25 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

04

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depottablett

Dosage Strength : 25 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

05

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depottablett

Dosage Strength : 50 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

06

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depottablett

Dosage Strength : 50 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depottablett

Dosage Strength : 50 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

08

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depot tablet

Dosage Strength : 50 mg

Packaging : Blisterpakning 30item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depot tablet

Dosage Strength : 50 mg

Packaging : Blisterpakning 90item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depot tablet

Dosage Strength : 25 mg

Packaging : Blisterpakning 30item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank